Jumatate Raluca, Werther-Evaldsson Anna, Ingvarsson Annika, Rådegran Göran, Meurling Carl Cronstedt, Ostenfeld Ellen
Department of Clinical Sciences Lund, Cardiology, Lund University, Entrégatan 7, Lund 221 85, Sweden.
Section for Heart Failure and Valvular Disease, Skane University Hospital, Entrégatan 7, Lund 221 85, Sweden.
Eur Heart J Imaging Methods Pract. 2024 Dec 3;2(3):qyae128. doi: 10.1093/ehjimp/qyae128. eCollection 2024 Jul.
Right ventricular (RV) failure causes high mortality in patients with pulmonary arterial hypertension (PAH). RV stroke work index (RVSWi) poses as a potential predictor of outcome. We evaluated how RVSWi by echocardiography (ECHO) or right heart catheterization (RHC) is altered following PAH treatment and if RVSWi is an indicator of outcome in PAH.
Fifty-four patients with PAH performed ECHO and RHC (median, 0 days between examinations) at baseline and treatment follow-up. RVSWi was computed as (mPAP-mRAP)×SVi, (mPAP, mean pulmonary arterial pressure; mRAP, mean right atrial pressure; SVi, stroke volume indexed to body surface area). ECHO-derived RVSWi was calculated as RVSWi = TRPG × SVi and RVSWi = TRPG × SVi (TRPG and TRPG: tricuspid regurgitant mean and maximum pressure gradient). Invasive sPAP, mPAP, and pulmonary vascular resistance decreased and SVi increased from baseline to follow-up ( < 0.01 for all). RVSWi and RVSWi (Mean and Max) did not differ from baseline to follow-up ( > 0.05). Forty patients died during 109 ± 24 months. In univariate Cox proportional hazard analysis, age > 65 years, 6-minute-walk test < 160 m, WHO class III-IV and indexed right atrial volume were associated with long-term mortality, but none of the RVSWi methods. In multivariate analysis with clinical parameters, both RVSWi methods were independently associated with mortality.
The RVSWi methods did not differ from baseline to short-term follow-up and were not associated with long-term outcomes in univariate analysis. However, baseline RVSWi was associated with mortality when adjusting for clinical parameters.
右心室(RV)衰竭导致肺动脉高压(PAH)患者的死亡率很高。右心室每搏功指数(RVSWi)是一种潜在的预后预测指标。我们评估了经超声心动图(ECHO)或右心导管检查(RHC)测得的RVSWi在PAH治疗后如何变化,以及RVSWi是否为PAH患者预后的指标。
54例PAH患者在基线和治疗随访时进行了ECHO和RHC检查(两次检查间隔的中位数为0天)。RVSWi计算公式为(平均肺动脉压 - 平均右心房压)× 体表面积指数每搏量(mPAP,平均肺动脉压;mRAP,平均右心房压;SVi,体表面积指数每搏量)。通过ECHO得出的RVSWi计算公式为RVSWi = 三尖瓣反流平均压差 × SVi以及RVSWi = 三尖瓣反流最大压差 × SVi(TRPG和TRPG:三尖瓣反流平均和最大压力阶差)。从基线到随访,有创收缩期肺动脉压、平均肺动脉压和肺血管阻力降低,而体表面积指数每搏量增加(所有P均<0.01)。从基线到随访,RVSWi以及RVSWi(均值和最大值)无差异(P>0.05)。40例患者在109±24个月期间死亡。在单因素Cox比例风险分析中,年龄>65岁、6分钟步行试验<160 m、世界卫生组织功能分级III - IV级以及右心房容积指数与长期死亡率相关,但与任何RVSWi测量方法均无关。在对临床参数进行多因素分析时,两种RVSWi测量方法均与死亡率独立相关。
从基线到短期随访,RVSWi测量方法无差异,且在单因素分析中与长期预后无关。然而,在对临床参数进行校正时,基线RVSWi与死亡率相关。